Article
Capture of a dimeric intermediate during transthyretin amyloid formation.
The Journal of biological chemistry - 26 Oct 2001
Olofsson A, Ippel H J, Baranov V, Hörstedt P, Wijmenga S, Lundgren E
Abstract excerpt
Point mutations in the human plasma protein transthyretin are associated with the neurological disorder familial amyloidosis with polyneuropathy type 1. The disease is characterized by amyloid fibril deposits causing damage at the site of deposition. Substitution of two amino acids in the hydrophobic core of transthyretin lead to a mutant that was very prone to form amyloid. In addition, this mutant has also been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
